11.100.30 标准查询与下载

DIN 58907-1:2000 止血学.凝血因子IX凝血剂活性的测定(F IX C).第1部分:一个阶段法用参考测量方法

The document is applicable to the determination of the factor IX coagulant activity in plasma and factor concentrates by the one-stage method. The purpose of this document is to achieve comparable results for the factor IX content in a given specimen.

Haemostaseology - Determination of factor IX coagulant activity (F IX C) - Part 1: Reference measurement procedure for the one-stage method

DIN 58906-1:2000 止血学.纤维蛋白原浓度测定.第1部分:按测定条款中规定的可凝固的纤维蛋白原的参考测量方法

Haemostaseology - Determination of fibrinogen concentration - Part 1: Reference measurement procedure for the determination of clottable fibrinogen as described by Clauss

DIN 58905-1:2000 止血学.采血.凝固试验用从含枸橼酸盐静脉血中提取血浆，对试验血浆的制备

The document is applicable to collection and processing of citrated venous blood for coagulation tests such as determination of thromboplastin (prothrombin) time, determination of activated partial thromboplastin time (APTT), determination of thrombin time, fibrinogen determination, determination of coagulation factors, and for other coagulation tests using plasma from citrated venous blood as sample. Specifications are made for standardization of the collection and processing of citrated venous blood in order to eliminate interference factors which can affect and falsify test results.#,,#

Haemostaseology - Blood collection - Part 1: Preparation of plasma from citrated venous blood for coagulation testing

DIN 58903:2000 止血学.不完全血浆.要求和制备

The document is applicable to deficient plasma which, using the one-step method are used for the quantitative determination of the coagulation factors II, V, VII, IX, X, XI or XII as well of the coagulation inhibitors protein C or protein S. The purpose is to avoid affecting the results of the determination of the coagulation factors using the one-step method caused by differences in the composition of the deficient plasma.

Haemostaseology - Deficient plasma - Requirements, preparation

DIN 58902:2000 止血学.测定凝血时间的参考测量程序

The document is applicable to determination of batroxobin time in plasma from citrated venous blood. Most fibrin polymerisation disorders increase the batroxobin time. Batroxobin time is not effected by heparin, heparinoids or hirudin. It is therefore used to determine the inhibiting effect of fibrin degradation products as well as detect hypofibrinogenaemias and dysfibrinogenaemias. Futhermore, the batroxobin time may be used to determine whether heparin has an effect on the thrombin time.

Haemostaseology - Reference measurement procedure for the determination of batroxobin time

DIN 58901-2:2000 止血学.因子Ⅶ凝血剂活性(FⅦ C)的测定.第2部分:采用合成肽底物的参考测量程序

Haemostaseology - Determination of factor VII coagulant activity (F VII C) - Part 2: Reference measurement procedure using a synthetic peptide substrate

DIN 58901-1:2000 止血学.因子Ⅶ凝血剂活性(FⅦ C)的测定.第1部分:一个阶段方法用参考测量程序

The document is applicable to the determination of the factor VII coagulant activity in plasma by using the one-stage method; however, it is not applicable to factor VII concentrates. The purpose of this standard is to achieve comparable results for the factor VII C content in a given plasma sample. Essential precondtions for achieving this objective are a standardized procedure for calibration of the method, as well as the use of reference plasmas with a declared factor VII C proportion which has been determined by calibration against the International Standard of WHO (plasma) for factor VII C which is valid at the time of use.

Haemostaseology - Determination of factor VII coagulant activity (F VII C) - Part 1: Reference measurement procedure for the one-stage method

DIN 58932-2:1998 血液学.血液中血细胞浓度的测定.第2部分:红细胞特征数量(红细胞指数)

This document is applicable to the characteristics quantities for erythrocytes. The purpose of this standard is to achieve comparable results for these characterstic quantities by establishing codes, letter symbols and units.#,,#

Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)

DIN 58904:1998 止血学.C蛋白活性的测定.肽基色谱参照测量程序

The document is applicable to the determination of protein C activity in plasma and protein C concentrates using a chromogenic peptide substrate. The purpose is to achieve comparable results for the protein C content in a given sample. Essential preconditions for achieving this objective are a standardized procedure for calibration of the method as well as the use or reference materials with a defined protein C content. which has been determined by calibration against the International Standard of WHO for protein C valid at the time of use.

Haemostaseology - Determination of protein C activity - Reference measurement procedure with a chromogenic peptide substrate

DIN 58934-1:1997 血液学.血象监控材料.第1部分:监控血液

The document is applicable to control bloods used for the routine quality control of analyzers.

Haematology - Control material for the CBC - Part 1: Control bloods

DIN 58935-1:1997 血液学.血液中红细胞沉降测定.第1部分:选定的方法

The document is applicable to the determination of the electrocyte sedimentation rate in human blood, which is used as a diagnostic aid. The result of this determination is dependent upon the characteristics of the blood cells and the blood plasma as well as the circumstances under which the determination is carried out. The correlations, however, are not yet completely understood. The specifications aim to provide comparability of the measurement result.#,,#

Haematologie - Determination of the erythrocyte sedimentation rate in blood - Part 1: Selected method

ASTM E961-97(2013) 一次性温特罗布氏玻璃血沉管的标准规范

1.1 This specification covers reusable blood sedimentation tubes suitable for determining sedimentation rates and the volume of packed red blood cells. 1.2 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

Standard Specification for Blood Sedimentation Tube, Wintrobe, Glass, Reusable

DIN 58932-1:1996 血液学.血球浓度测定.第1部分:采血、试样制备、生物影响因素、干扰因素

The document is applicable to blood collection for the determination of the concentration of blood corpuscles in human blood which has been made non-coagulation by the addition of anti-coagulants or by dilution with an isotone aqueous solution.

Haematology - Determination of the concentration of blood corpuscles in blood - Part 1: Blood collection, sample preparation, biological influence factors, interference factors

ISO 6710:1995 一次性使用静脉血样采集容器

Specifies requirements and test methods for evacuated and non-evacuated single-use venous blood specimen containers. Does not apply for blood collection needles.

Single-use containers for venous blood specimen collection

CAN/CGSB-106.5-1995 血型试剂和抗人球蛋白试剂

1. Objet 1.1 La présente norme contient les exigences minimales relatives à l'activité et à la spécificité des quatre principaux groupes de réactifs utilisés au Canada pour la détermination des groupes sanguins: réactifs de groupage ABO; réactifs anti-D de groupage Rh; réactifs de groupage Rh autres que l'anti-D; et réactifs antiglobuline humaine. 1.2 Ces réactifs sont des liquides biologiques d'origine humaine ou animale. Ces produits peuvent avoir subi ou non des modifications chimiques, ou avoir été fabriqués au moyen d'anticorps monoclonaux préparés à partir de cultures de lignées cellulaires. 1.3 La présente norme s'applique, le cas échéant, aux techniques suivantes: en tubes, sur microplaques en phase liquide, par agglutination sur colonne, sur gel, en phase solide, ainsi qu'aux techniques automatisées. La méthode sur lame n'est pas recommandée comme technique de choix pour les essais courants. 1.4 Les usagers qui évaluent les lots de réactifs doivent suivre les Normes de la médecine transfusionnelle émises par la Société canadienne de médecine transfusionnelle. Ils devraient évaluer les nouveaux lots de réactifs en comparant leur réactivité avec celle des réactifs utilisés pour la méthode courante du laboratoire qui donnent des résultats satisfaisants. Les témoins appropriés doivent être utilisés. Les usagers peuvent adresser les plaintes concernant les réactifs au Bureau des matériaux médicaux, Direction de l'hygiène du milieu, Santé Canada, Bloc 1600, Immeuble principal de Statistique Canada, Pré Tunney, Ottawa Ontario K1A 0L2. 1.5 La mise à l'essai et l'évaluation d'un produit en regard de la présente norme peuvent nécessiter l'emploi de matériaux ou d'équipement susceptibles d'être dangereux. Le présent document n'entend pas traiter de tous les aspects liés à la sécurité de son utilisation. Il appartient à l'usager de la norme de se renseigner auprès des autorités compétentes et d'adopter des pratiques d'hygiène et de sécurité conformes aux règlements en vigueur avant de l'utiliser, tels que les dispositions du Règlement sur les instruments médicaux qui portent sur les instruments médicaux contenant des produits d'origine humaine ou animale capables de transmettre l'hépatite et/ou le virus de l'immunodéficience humaine (VIH).

Blood grouping reagents and anti-human globulin reagents

DIN 58933-1:1995 血液学.血液中红血球(包裹细胞容积)容积率的测定程序.第1部分:基于离心作用的基准法

The centrifugation method for the determination of the volume fraction of native erythrocytes in blood is used to determine the target data for comparative measurements in the framework of interlaboratory round tests as well as for the calibration of systems used for blood analysis.

Haematology - Procedure for determining the volume fraction of erythrocytes (packed cell volume) in blood - Part 1: Reference method based on centrifugation

AS 4205.2:1994 尿液的微量元素分析．铜,镉和铅含量的测定．火焰原子吸收光谱法

Specifies a flame atomic absorption spectrometric method using direct aspiration of the extracted iodide complexes into an air/acetylene flame, for the determination of copper, cadmium or lead in urine. The method is suitable for the following ranges of cadmium 0.02 to 0.20 μmol, copper 0.30 to 4.00 μmol and lead 0.10 to 2.00 μmol.

Analysis of urine for trace elements - Determination of copper, cadmium and lead - Flame atomic absorption spectrometric method

DIN 58932-3:1994 血液学.血液中血球浓度的测定.红血球浓度的测定.第3部分:基准法

Haematology; determination of the concentration of blood corpuscles in blood; determination of the concentration of erythrocytes; reference method

AS 2636:1994 铅或镉浓度测定用静脉血和毛细血管血采样

Specifies the procedures for the sampling of blood, using needle and syringes or vacuum systems, for the subsequent determination of cadmium or lead. The Standard also includes appendices which describe the method for determining the contaminant analyte level in collection equipment, containers and swabs.

Sampling of venous and capillary blood for the determination of lead or cadmium concentration

AS 2411:1993 静脉血．铅含量测定．火焰原子吸收光谱法

Sets out a flame atomic absorption spectrometric method for the determination of lead in venous blood after extraction into n-butyl acetate. The method is applicable to the determination of lead in whole blood in the range of 1.0 μmol/L to 60 μmol/L.

Venous blood - Determination of lead content - Flame atomic absorption spectrometric method